FindTrial
Sign In

The value of 18F-ML-10 PET/CT imaging to evaluate the early response after radiotherapy in esophagus cancer

The value of 18F-ML-10 PET/CT imaging to evaluate the early response after radiotherapy in esophagus cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018062
Enrollment
Unknown
Registered
2018-08-28
Start date
2018-08-28
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophagus cancer

Interventions

Gold Standard:Pathological diagnosis, Clinical outcome
Index test:18F-ML-10 PET/CT

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with locally advanced esophageal cancer by pathology and imaging and planned to radiotherapy; Age from 18 to 79 years male and female.

Exclusion criteria

Exclusion criteria: 1. Patients who have received radiotherapy and chemotherapy within half a year; 2. Allergic constitution; 3. Unable to cooperate with examination; 4. Patients with severe basic diseases.

Design outcomes

Primary

MeasureTime frame
SUV;—

Secondary

MeasureTime frame
tumor size;—

Countries

China

Contacts

Public ContactBing Cheng

Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University

chengbing@zzu.edu.cn+86 13673665157

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026